Dr. Kuusk begins with the reporting of several new trials and the accompanying results, which include: Phase 3 CheckMate-914, Phase 3 COSMIC-313, Phase 2 Keynote-B61, and Cohort 1 of LITESPARK-003 study.
After delivering the trial results, Dr. Kuusk shares the possible reasons why the adjuvant trials failed.
For more details on the results of the LITESPARK-003 study, you can watch this video featuring Assoc. Prof. Jaime Merchan (US), who presented at ESMO2022. https://kidney.uroonco.uroweb.org/video/cohort-1-of-litespark-003/
This article was first posted on UROONCO.
If you would like to listen to more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates.
Contact our organiser